Pouches, Ileoanal clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
open to eligible people ages 18-80
The goal of this clinical trial is to learn if mirikizumab works to treat pouch disorders in adults. The main questions it aims to answer are: Does mirikizumab reduce symptoms of pouch disorders Participants will: Take mirikizumab every 4 weeks for one year Visit the clinic once every month for two months and at the end of the study Keep a diary of their symptoms
at UCLA
Our lead scientists for Pouches, Ileoanal research studies include Gaurav Syal, MD.
Last updated: